Serum Institute's 2nd Covid vaccine likely to be launched in September

Gallery

MORE...

Sports

Laureus Award 2024 : Novak Djokovic, Aitana Bonmati win top honours at Laureus Sports Awards

World no. 1 Serbian tennis great Novak Djokovic was named Laureus World Sportsman of the Y

Asian Games medallist Jyothi Yarraji to train in Spain ahead of Paris Olympics

Lione Messi said Retirement not on my mind

Indian Wells: Alcaraz, Swiatek win titles

African footballer chased and thrashed away in Kerala; reports

Hockey India announce core probable group for men's national camp in Bhubaneswar

MORE...

Serum Institute's 2nd Covid vaccine likely to be launched in September

Last Updated : 27 Mar 2021 03:18:58 PM IST

Serum Institute CEO Adar Poonawalla

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax by September this year, CEO Adar Poonawalla announced on Saturday.

"Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India," said Adar Poonawalla.

He further said that it has been tested against African and UK variants of Covid-19 and has an overall efficacy of 89 per cent. "Hope to launch by September 2021!" the CEO of world's biggest Covid-19 vaccine maker said.

Covovax is the protein-based Covid-19 vaccine developed by Novavax, headquartered in the US.

In August 2020, the two companies announced an agreement under which Novavax had given SII the licence to manufacture and supply the vaccine in low- and middle-income countries.